Arcutis Biotherapeutics, Inc. - ARQT
Officer
Reporting Person's title: SVP General Counsel and
Direct Buys
2
$18,543
5,657
Shares
Direct Sells
7
($348,660)
-30,416
Shares
Indirect Buys
0
$0
0
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
05/02/2025
|
05/05/2025 |
Sell
|
-5,030 @ $15.20
|
($76,453) | 204,399 (-2.40%) | Direct |
|
03/03/2025
|
03/04/2025 |
Sell
|
-3,263 @ $13.03
|
($42,520) | 209,429 (-1.53%) | Direct |
|
02/03/2025
|
02/04/2025 |
Sell
|
-8,338 @ $12.70
|
($105,893) | 178,692 (-4.46%) | Direct |
|
11/30/2024
|
12/03/2024 |
Buy
|
1,657 @ $7.11
|
$11,775 | 187,030 (0.89%) | Direct |
|
11/19/2024
|
11/19/2024 |
Sell
|
-1,775 @ $9.68
|
($17,190) | 181,373 (-0.97%) | Direct |
|
11/04/2024
|
11/05/2024 |
Sell
|
-5,015 @ $8.68
|
($43,551) | 178,273 (-2.74%) | Direct |
|
08/02/2024
10b5-1
|
08/05/2024 |
Sell
|
-5,220 @ $9.02
|
($47,064) | 183,288 (-2.77%) | Direct |
|
05/31/2024
|
12/03/2024 |
Buy
|
4,000 @ $1.69
|
$6,768 | 185,373 (2.21%) | Direct |
|
05/28/2024
|
05/29/2024 |
Sell
|
-1,775 @ $9.01
|
($15,988) | 188,508 (-0.93%) | Direct |